$MNTS
Momentus Inc. Stock $mnts

$mnts Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000178116222000057 Filed on May 11, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$0.00	$130.0K
YoY Change	-100.0%
Cost Of Revenue	$0.00	$48.00K
YoY Change	-100.0%
Gross Profit	$0.00	$82.00K
YoY Change	-100.0%
Gross Profit Margin		63.08%
Selling, General & Admin	$14.85M	$14.01M
YoY Change	6.05%	5735.42%
% of Gross Profit		17079.27%
Research & Development	$9.971M	$9.906M
YoY Change	0.66%
% of Gross Profit		12080.49%
Depreciation & Amortization	$300.0K	$200.0K
YoY Change	50.0%
% of Gross Profit		243.9%
Operating Expenses	$24.82M	$23.91M
YoY Change	3.82%	9862.92%
Operating Profit	-$24.82M	-$23.83M
YoY Change	4.18%
Interest Expense	$1.492M	$968.0K
YoY Change	54.13%	44.48%
% of Operating Profit
Other Income/Expense, Net	-$2.010M	$88.50M
YoY Change	-102.27%
Pretax Income	-$26.83M	$64.67M
YoY Change	-141.49%	14939.77%
Income Tax
% Of Pretax Income
Net Earnings	-$26.83M	$64.67M
YoY Change	-141.49%	-1133.91%
Net Earnings / Revenue		49746.92%
Basic Earnings Per Share	-$0.34	$1.03
Diluted Earnings Per Share	-$0.34	-$0.28
COMMON SHARES
Basic Shares Outstanding	79.96M shares	62.73M shares
Diluted Shares Outstanding	79.96M shares	87.68M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$135.6M	$208.6K
YoY Change	64921.34%	-79.15%
Cash & Equivalents	$135.6M	$57.59M
Short-Term Investments
Other Short-Term Assets	$8.084M	$493.2K
YoY Change	1539.26%	146.58%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$143.7M	$701.7K
YoY Change	20376.84%	-41.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.726M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$173.0M
YoY Change		-0.22%
Other Assets	$5.750M
YoY Change
Total Long-Term Assets	$18.74M	$173.0M
YoY Change	-89.17%	-0.22%
TOTAL ASSETS
Total Short-Term Assets	$143.7M	$701.7K
Total Long-Term Assets	$18.74M	$173.0M
Total Assets	$162.4M	$173.7M
YoY Change	-6.5%	-0.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.289M
YoY Change
Accrued Expenses	$9.568M	$4.830M
YoY Change	98.09%	4730.23%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$600.0K
YoY Change	-100.0%
Long-Term Debt Due	$9.432M
YoY Change
Total Short-Term Liabilities	$34.52M	$5.430M
YoY Change	535.74%	1710.08%
LONG-TERM LIABILITIES
Long-Term Debt	$11.30M	$0.00
YoY Change
Other Long-Term Liabilities	$488.0K	$46.26M
YoY Change	-98.95%	570.41%
Total Long-Term Liabilities	$26.65M	$46.26M
YoY Change	-42.39%	570.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$34.52M	$5.430M
Total Long-Term Liabilities	$26.65M	$46.26M
Total Liabilities	$61.17M	$51.69M
YoY Change	18.34%	617.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$235.5M
YoY Change
Common Stock	$1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$101.3M	-$219.0M
YoY Change
Total Liabilities & Shareholders Equity	$162.4M	$173.7M
YoY Change	-6.5%	-0.5%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$26.83M	$64.67M
YoY Change	-141.49%	-1133.91%
Depreciation, Depletion And Amortization	$300.0K	$200.0K
YoY Change	50.0%
Cash From Operating Activities	-$23.06M	-$21.20M
YoY Change	8.79%	9116.96%
INVESTING ACTIVITIES
Capital Expenditures	$290.0K	$429.0K
YoY Change	-32.4%
Acquisitions
YoY Change
Other Investing Activities		$1.000K
YoY Change		-99.17%
Cash From Investing Activities	-$521.0K	-$431.0K
YoY Change	20.88%	-459.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$938.0K	$55.70M
YoY Change	-101.68%
NET CHANGE
Cash From Operating Activities	-$23.06M	-$21.20M
Cash From Investing Activities	-$521.0K	-$431.0K
Cash From Financing Activities	-$938.0K	$55.70M
Net Change In Cash	-$24.52M	$34.07M
YoY Change	-171.97%	-31073.64%
FREE CASH FLOW
Cash From Operating Activities	-$23.06M	-$21.20M
Capital Expenditures	$290.0K	$429.0K
Free Cash Flow	-$23.35M	-$21.63M
YoY Change	7.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001781162
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2022Q1	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2021Q1	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2021Q1	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-39128
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	Momentus Inc.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	197000	USD
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1905538
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3901 N. First Street
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Jose
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95134
CY2022Q1	dei	City Area Code CityAreaCode	650
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	564-7820
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	81755715	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	135602000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	160036000	USD
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	100000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7984000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9431000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	143686000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	169664000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4726000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4829000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	656000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	349000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7282000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7604000	USD
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	324000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	314000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5750000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3065000	USD
CY2022Q1	us-gaap	Assets Assets	162424000	USD
CY2021Q4	us-gaap	Assets Assets	185825000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3289000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1911000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9568000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9785000	USD
CY2022Q1	us-gaap	Loans Payable Current LoansPayableCurrent	9432000	USD
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	20907000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1143000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1189000	USD
CY2022Q1	mnts	Share Repurchase Liability Current ShareRepurchaseLiabilityCurrent	6000000	USD
CY2021Q4	mnts	Share Repurchase Liability Current ShareRepurchaseLiabilityCurrent	0	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5090000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5075000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	34522000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	38867000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1654000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1554000	USD
CY2022Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	11303000	USD
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	0	USD
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6200000	USD
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5749000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7002000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7284000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	488000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	483000	USD
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	26647000	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	15070000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	61169000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	53937000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81755715	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81755715	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	142804498	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81211781	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81211781	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	336771000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	340570000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-235517000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-208683000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	101255000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	131888000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	162424000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	185825000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	130000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	48000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	0	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	82000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9971000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9906000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14853000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14005000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	24824000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	23911000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-24824000	USD
CY2021Q4	mnts	Prepaid Launch Costs Noncurrent PrepaidLaunchCostsNoncurrent	3000000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-23829000	USD
CY2022Q1	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	0	USD
CY2021Q1	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	81564000	USD
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	451000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8083000	USD
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-70000	USD
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	1492000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	968000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-179000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2010000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	88500000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-26834000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	64671000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.03
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79958383	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62733080	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79958383	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87684818	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	131888000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	48000	USD
CY2022Q1	mnts	Stock Issued During Period Value Section16 Officer Tax Coverage Exchange StockIssuedDuringPeriodValueSection16OfficerTaxCoverageExchange	59000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2212000	USD
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6000000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-26834000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	101255000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-289472000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	24000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5768000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	64671000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-219009000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-26834000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	64671000	USD
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	294000	USD
CY2021Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	199000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	742000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	718000	USD
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	13000	USD
CY2021Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	451000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8083000	USD
CY2022Q1	mnts	Fair Value Adjustment Of Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentOfFinancialInstrumentsSubjectToMandatoryRedemption	0	USD
CY2021Q1	mnts	Fair Value Adjustment Of Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentOfFinancialInstrumentsSubjectToMandatoryRedemption	-81564000	USD
CY2022Q1	mnts	Prepaid Launch Costs Impairment Charges PrepaidLaunchCostsImpairmentCharges	0	USD
CY2021Q1	mnts	Prepaid Launch Costs Impairment Charges PrepaidLaunchCostsImpairmentCharges	750000	USD
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-70000	USD
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2212000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5768000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1447000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9246000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2685000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-93000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1387000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-97000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-273000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5120000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	14000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	80000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	100000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	146000	USD
CY2022Q1	mnts	Increase Decrease In Operating Lease Liability And Operating Right Of Use Asset IncreaseDecreaseInOperatingLeaseLiabilityAndOperatingRightOfUseAsset	6000	USD
CY2021Q1	mnts	Increase Decrease In Operating Lease Liability And Operating Right Of Use Asset IncreaseDecreaseInOperatingLeaseLiabilityAndOperatingRightOfUseAsset	-245000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	6000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23062000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21199000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	290000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	429000	USD
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	231000	USD
CY2021Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-521000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-431000	USD
CY2022Q1	mnts	Proceeds From Issuance Of Financial Instruments Subject To Mandatory Redemption ProceedsFromIssuanceOfFinancialInstrumentsSubjectToMandatoryRedemption	0	USD
CY2021Q1	mnts	Proceeds From Issuance Of Financial Instruments Subject To Mandatory Redemption ProceedsFromIssuanceOfFinancialInstrumentsSubjectToMandatoryRedemption	30853000	USD
CY2022Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2021Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	25000000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	48000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	24000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	59000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	927000	USD
CY2021Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	144000	USD
CY2022Q1	mnts	Payment Of Warrant Issuance Costs PaymentOfWarrantIssuanceCosts	0	USD
CY2021Q1	mnts	Payment Of Warrant Issuance Costs PaymentOfWarrantIssuanceCosts	31000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-938000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	55702000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-24521000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	34071000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	160547000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23520000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	136026000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57591000	USD
CY2022Q1	mnts	Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction Included In Accounts Payable And Accrued Expenses DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransactionIncludedInAccountsPayableAndAccruedExpenses	0	USD
CY2021Q1	mnts	Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction Included In Accounts Payable And Accrued Expenses DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransactionIncludedInAccountsPayableAndAccruedExpenses	861000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8501000	USD
CY2022Q1	us-gaap	Accelerated Share Repurchases Adjustment To Recorded Amount AcceleratedShareRepurchasesAdjustmentToRecordedAmount	6000000	USD
CY2021Q1	us-gaap	Accelerated Share Repurchases Adjustment To Recorded Amount AcceleratedShareRepurchasesAdjustmentToRecordedAmount	0	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	750000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	250000	USD
CY2022Q1	us-gaap	Nature Of Operations NatureOfOperations	Nature of Operations<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Momentus Inc. (together with its consolidated subsidiaries “Momentus” or the “Company”) is a U.S. commercial space company that plans to offer in-space infrastructure services, including in-space transportation, hosted payloads and in-orbit services. Momentus believes it can make new ways of operating in space possible with its planned in-space transfer and service vehicles that will be powered by an innovative water plasma-based propulsion system that is under development. The Company anticipates flying its Vigoride vehicle to Low Earth Orbit on a third-party launch provider as early as May 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject to receipt of licenses and government approvals, and successful completion of our current efforts to get the system ready for flight.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 4, 2022, as a subsequent event, the Company received a favorable determination from the Federal Aviation Administration (the “FAA”) of its application for payload review in support of the Company’s inaugural flight of the Vigoride orbital transfer vehicle on the launch targeted for May 2022. Together with a license from the Federal Communications Commission (the “FCC”) received on April 28, 2022, and updates to existing licenses from the National Oceanic and Atmospheric Administration (the “NOAA”), the Company has received all required government approvals required for its inaugural flight. See Note 14.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background and Business Combination</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2021, the Company consummated a merger pursuant to certain Agreement and Plan of Merger, dated October 7, 2020, and as amended on March 5, 2021, April 6, 2021, and June 29, 2021 (the “Merger Agreement”), by and among Stable Road Acquisition Corp (“SRAC”), Project Marvel First Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of SRAC (“First Merger Sub”), and Project Marvel Second Merger Sub, LLC, a Delaware limited liability company and a direct, wholly owned subsidiary of SRAC (“Second Merger Sub”), pursuant to which First Merger Sub merged with and into Momentus Inc., a Delaware corporation (“Legacy Momentus”) with Legacy Momentus as the surviving corporation of the First Merger Sub, and immediately following which Legacy Momentus merged with and into the Second Merger Sub, with the Second Merger Sub as the surviving entity (the “Business Combination”). In connection with the closing of the Business Combination (the “Closing”), the Company changed its name from Stable Road Acquisition Corp. to Momentus Inc., and Legacy Momentus changed its name to Momentus Space, LLC. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger was accounted for as a reverse recapitalization under ASC Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ("ASC 805") in accordance with accounting principles generally accepted in the United States (“GAAP”). Under this method of accounting, SRAC, who was the legal acquirer, is treated as the “acquired” company for financial reporting purposes and Legacy Momentus is treated as the accounting acquirer. Accordingly, for accounting purposes, the Merger is treated as the equivalent of a capital transaction in which Legacy Momentus issued stock for the net assets of SRAC, with no goodwill or other intangible assets recorded, and Legacy Momentus’ financial statements became those of the Company. Reported shares and earnings per share available to holders of the Company’s common stock, prior to the Business Combination, have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination. See Note 3 for more information.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Amended and Restated Certificate of Incorporation of the Company, at the Closing, each share of SRAC’s Class B Common Stock, par value $0.0001 per share (the “Class B Common Stock”), converted into one share of SRAC’s Class A Common Stock. After the Closing and following the effectiveness of the Second Amended and Restated Certificate of Incorporation of the Company, each share of Class A Common Stock was automatically reclassified, redesignated and changed into one validly issued, fully paid and non-assessable share of the Company’s Common Stock, par value $0.00001 per share (the “Common Stock”), without any further action by the Company or any stockholder thereof. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, SRAC’s units, public shares, and public warrants were listed on the Nasdaq under the symbols “SRACU,” “SRAC,” and “SRACW,” respectively. On August 13, 2021, the Company's Class A common stock and public warrants began trading on the Nasdaq, under the symbols “MNTS” and “MNTSW,” respectively.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2020 and July 15, 2021, SRAC entered into subscription agreements with certain investors (the “PIPE Investors”) to which such investors collectively subscribed for an aggregate of 11,000,000 shares of the Company’s Class A common stock at $10.00 per share for aggregate gross proceeds of $110.0 million (the “PIPE Investment”). The PIPE Investors were also granted an equal number of private warrants to purchase the Company’s Class A common stock at $11.50 per share. The warrants were recorded as a derivative liability under ASC Topic 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (“ASC 815”) and the warrant liability was initially valued at $30.5 million. See Note 11 for more information. The PIPE Investment was consummated concurrently with the closing of the Merger.</span>
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Management bases its estimates on historical experience and on various other factors it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Accordingly, actual results could differ from those estimates. Significant estimates inherent in the preparation of the financial statements include, but are not limited to, accounting for useful lives of property, machinery and equipment, net, intangible assets, net, accrued liabilities, income taxes including deferred tax assets and liabilities, impairment valuation, stock-based awards, SAFE notes and warrant liabilities.
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	11000000	shares
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	USD
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	30500000	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Certain reclassifications have been made to the prior year’s financial statements to conform to the current year’s presentation. None of the reclassifications have changed the total assets, liabilities, stockholders’ deficit, income, expenses or net losses previously reported.
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period Stock Price Trigger ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriodStockPriceTrigger	12.00
CY2022Q1	mnts	Deferred Fulfillment And Prepaid Launch Costs DeferredFulfillmentAndPrepaidLaunchCosts	5700000	USD
CY2021Q4	mnts	Deferred Fulfillment And Prepaid Launch Costs DeferredFulfillmentAndPrepaidLaunchCosts	3000000	USD
CY2021	mnts	Number Of Launch Agreements Terminated NumberOfLaunchAgreementsTerminated	2	agreement
CY2021Q2	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	USD
CY2021Q2	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	USD
CY2021Q1	mnts	Other Impairment Of Ongoing Project OtherImpairmentOfOngoingProject	800000	USD
CY2021Q4	mnts	Deferred Fulfillment And Prepaid Launch Costs Recoveries DeferredFulfillmentAndPrepaidLaunchCostsRecoveries	2700000	USD
CY2022Q1	mnts	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	1700000	USD
CY2021	mnts	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	1600000	USD
CY2022Q1	mnts	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	1700000	USD
CY2021	mnts	Contract With Customer Liability Revenue Recognized For Cancelled Contracts ContractWithCustomerLiabilityRevenueRecognizedForCancelledContracts	300000	USD
CY2021	mnts	Reduction In Cost Of Goods And Services Sold ReductionInCostOfGoodsAndServicesSold	100000	USD
CY2021Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	1400000	USD
CY2022Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash and cash equivalents in banks that management believes are creditworthy, however deposits may exceed federally insured limits.
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021Q3	mnts	Reverse Recapitalization Percentage Of Voting Interests Sold ReverseRecapitalizationPercentageOfVotingInterestsSold	1
CY2021Q3	mnts	Reverse Recapitalization Proceeds Received From Shareholders ReverseRecapitalizationProceedsReceivedFromShareholders	247300000	USD
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	USD
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	137300000	USD
CY2021Q3	mnts	Reverse Recapitalization Public Investment ReverseRecapitalizationPublicInvestment	172500000	USD
CY2021Q3	mnts	Reverse Recapitalization Redemptions ReverseRecapitalizationRedemptions	35600000	USD
CY2021Q3	mnts	Reverse Recapitalization Impact On Shareholders Equity ReverseRecapitalizationImpactOnShareholdersEquity	8500000	USD
CY2021Q3	mnts	Reverse Recapitalization Proceeds Received In Cash From Operations ReverseRecapitalizationProceedsReceivedInCashFromOperations	400000	USD
CY2021Q3	mnts	Reverse Recapitalization Net Proceeds Received From Shareholders ReverseRecapitalizationNetProceedsReceivedFromShareholders	238800000	USD
CY2021Q3	mnts	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	27800000	USD
CY2021Q3	mnts	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	4800000	USD
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriod	P6M
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period Threshold Trading Days ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriodThresholdTradingDays	20	tradingDay
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period Threshold Consecutive Trading Days ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriodThresholdConsecutiveTradingDays	30	tradingDay
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	11000000	shares
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	USD
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	30500000	USD
CY2022Q1	mnts	Prepaid Research And Development Expense Current PrepaidResearchAndDevelopmentExpenseCurrent	4108000	USD
CY2021Q4	mnts	Prepaid Research And Development Expense Current PrepaidResearchAndDevelopmentExpenseCurrent	4870000	USD
CY2022Q1	mnts	Prepaid Insurance And Other Assets Current PrepaidInsuranceAndOtherAssetsCurrent	3876000	USD
CY2021Q4	mnts	Prepaid Insurance And Other Assets Current PrepaidInsuranceAndOtherAssetsCurrent	4562000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7984000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9431000	USD
CY2022Q1	mnts	Prepaid Launch Costs Noncurrent PrepaidLaunchCostsNoncurrent	5700000	USD
CY2021Q2	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	USD
CY2021Q2	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	USD
CY2021Q1	mnts	Other Impairment Of Ongoing Project OtherImpairmentOfOngoingProject	800000	USD
CY2021Q4	mnts	Deferred Fulfillment And Prepaid Launch Costs Recoveries DeferredFulfillmentAndPrepaidLaunchCostsRecoveries	2700000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6728000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6656000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2002000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1827000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4726000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4829000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	200000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	300000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	793000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	136000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	656000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	447000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	98000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	349000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	40000.00	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10000.00	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	170000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	170000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	162000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	58000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	44000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	52000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	656000	USD
CY2021Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2022Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11000000	USD
CY2021Q4	mnts	Lessee Operating Lease Number Of Leases Modified LesseeOperatingLeaseNumberOfLeasesModified	2	lease
CY2022Q1	mnts	Lessee Operating Lease Number Of Leases Modified LesseeOperatingLeaseNumberOfLeasesModified	1	lease
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	440000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	435000	USD
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	150000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	147000	USD
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	USD
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3000	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	591000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	586000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y10M24D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.057
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1188000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1533000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1580000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1627000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1674000	USD
CY2022Q1	mnts	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	2026000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9628000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1483000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	8145000	USD
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4942000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4121000	USD
CY2022Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1615000	USD
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3862000	USD
CY2022Q1	mnts	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	1903000	USD
CY2021Q4	mnts	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	1240000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	939000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	399000	USD
CY2022Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	168000	USD
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	163000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9568000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9785000	USD
CY2021Q1	mnts	Proceeds From Issuance Of Financial Instruments Subject To Mandatory Redemption ProceedsFromIssuanceOfFinancialInstrumentsSubjectToMandatoryRedemption	30900000	USD
CY2021Q3	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount SharesSubjectToMandatoryRedemptionSettlementTermsAmount	78000000	USD
CY2021Q3	mnts	Stock Issued During Period Value Conversion Of Safe Notes StockIssuedDuringPeriodValueConversionOfSAFENotes	136000000	USD
CY2021Q1	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	81600000	USD
CY2021Q3	mnts	Common And Preferred Stock Shares Authorized CommonAndPreferredStockSharesAuthorized	270000000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79772262	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.54
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	173883	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.28
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79772262	shares
CY2021Q3	mnts	Common Stock Percentage Of Ownership After Reverse Recapitalization CommonStockPercentageOfOwnershipAfterReverseRecapitalization	1
CY2021Q2	mnts	Reverse Recapitalization Percentage Of Voting Interests Acquired ReverseRecapitalizationPercentageOfVotingInterestsAcquired	1
CY2021Q2	mnts	Reverse Recapitalization Initial Consideration Transferred To Each Co Founder ReverseRecapitalizationInitialConsiderationTransferredToEachCoFounder	1	USD
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	50000000	USD
CY2021Q2	mnts	Reverse Recapitalization Proceeds Received From Shareholders ReverseRecapitalizationProceedsReceivedFromShareholders	247300000	USD
CY2021Q2	mnts	Reverse Recapitalization Payments To Co Founders ReverseRecapitalizationPaymentsToCoFounders	40000000	USD
CY2021Q2	mnts	Business Combination Initial Consideration Transferred To Co Founders BusinessCombinationInitialConsiderationTransferredToCoFounders	3	USD
CY2021Q2	mnts	Proceeds From Sale Of Business And Other Capital Raising Transactions From Co Founders Minimum ProceedsFromSaleOfBusinessAndOtherCapitalRaisingTransactionsFromCoFoundersMinimum	2700000	USD
CY2022Q1	mnts	Business Combination Contingent Consideration Liability To Co Founders BusinessCombinationContingentConsiderationLiabilityToCoFounders	6000000	USD
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4043492	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.27
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1064862	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	171331	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.28
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4763140	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.77
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	11510000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2682330	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.26
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3M18D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	7856000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4763140	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.77
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y4M24D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	11510000	USD
CY2021Q1	mnts	Financial Instruments Subject To Mandatory Redemption Increase Decrease To Equity Amount FinancialInstrumentsSubjectToMandatoryRedemptionIncreaseDecreaseToEquityAmount	81564000	USD
CY2022Q1	mnts	Warrants Fair Value Adjustment WarrantsFairValueAdjustment	0	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	400000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4900000	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2212000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5768000	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2212000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5768000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-26834000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	64671000	USD
CY2022Q1	mnts	Financial Instruments Subject To Mandatory Redemption Increase Decrease To Equity Amount FinancialInstrumentsSubjectToMandatoryRedemptionIncreaseDecreaseToEquityAmount	0	USD
CY2021Q1	mnts	Warrants Fair Value Adjustment WarrantsFairValueAdjustment	8081000	USD
CY2022Q1	mnts	Business Combination Contingent Consideration Liability To Co Founders BusinessCombinationContingentConsiderationLiabilityToCoFounders	6000000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-26834000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24974000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79958383	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62733080	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	6914766	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1163377	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	16873595	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79958383	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87684818	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2021Q2	mnts	Proceeds From Sale Of Business And Other Capital Raising Transactions From Co Founders Minimum ProceedsFromSaleOfBusinessAndOtherCapitalRaisingTransactionsFromCoFoundersMinimum	2700000	USD
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28478382	shares
CY2022Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	10277000	USD
CY2022Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary	11300000	USD
CY2022Q1	mnts	Unrecorded Unconditional Purchase Obligation To Be Paid After Year Two UnrecordedUnconditionalPurchaseObligationToBePaidAfterYearTwo	0	USD
CY2022Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	21577000	USD
CY2021Q2	mnts	Reverse Recapitalization Percentage Of Voting Interests Acquired ReverseRecapitalizationPercentageOfVotingInterestsAcquired	1
CY2021Q2	mnts	Reverse Recapitalization Initial Consideration Transferred To Each Co Founder ReverseRecapitalizationInitialConsiderationTransferredToEachCoFounder	1	USD
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	50000000	USD
CY2021Q2	mnts	Reverse Recapitalization Proceeds Received From Shareholders ReverseRecapitalizationProceedsReceivedFromShareholders	247300000	USD
CY2021Q2	mnts	Reverse Recapitalization Payments To Co Founders ReverseRecapitalizationPaymentsToCoFounders	40000000	USD
CY2021Q2	mnts	Business Combination Initial Consideration Transferred To Co Founders BusinessCombinationInitialConsiderationTransferredToCoFounders	3	USD
CY2022Q1	us-gaap	Legal Fees LegalFees	800000	USD
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0

Files In Submission

Name	View Source	Status
0001781162-22-000057-index-headers.html	Edgar Link	pending
0001781162-22-000057-index.html	Edgar Link	pending
0001781162-22-000057.txt	Edgar Link	pending
0001781162-22-000057-xbrl.zip	Edgar Link	pending
a20220331-ex311xceo.htm	Edgar Link	pending
a20220331-ex312xcfo.htm	Edgar Link	pending
a20220331-ex321xceo.htm	Edgar Link	pending
a20220331-ex322xcfo.htm	Edgar Link	pending
ex102formofoption.htm	Edgar Link	pending
ex102formofoption001.jpg	Edgar Link	pending
ex102formofoption002.jpg	Edgar Link	pending
ex102formofoption003.jpg	Edgar Link	pending
ex102formofoption004.jpg	Edgar Link	pending
ex102formofoption005.jpg	Edgar Link	pending
ex102formofoption006.jpg	Edgar Link	pending
ex102formofoption007.jpg	Edgar Link	pending
ex102formofoption008.jpg	Edgar Link	pending
ex102formofoption009.jpg	Edgar Link	pending
ex102formofoption010.jpg	Edgar Link	pending
ex102formofoption011.jpg	Edgar Link	pending
ex103formofrsu.htm	Edgar Link	pending
ex103formofrsu001.jpg	Edgar Link	pending
ex103formofrsu002.jpg	Edgar Link	pending
ex103formofrsu003.jpg	Edgar Link	pending
ex103formofrsu004.jpg	Edgar Link	pending
ex103formofrsu005.jpg	Edgar Link	pending
ex103formofrsu006.jpg	Edgar Link	pending
ex103formofrsu007.jpg	Edgar Link	pending
ex103formofrsu008.jpg	Edgar Link	pending
ex103formofrsu009.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mnts-20220331.htm	Edgar Link	pending
mnts-20220331.xsd	Edgar Link	pending
mnts-20220331_cal.xml	Edgar Link	unprocessable
mnts-20220331_def.xml	Edgar Link	unprocessable
mnts-20220331_htm.xml	Edgar Link	completed
mnts-20220331_lab.xml	Edgar Link	unprocessable
mnts-20220331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MNTS
Momentus Inc. Stock $mnts

2022 Q1 Form 10-Q Financial Statement

#000178116222000057 Filed on May 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNTS Momentus Inc. Stock $mnts

2022 Q1 Form 10-Q Financial Statement

#000178116222000057 Filed on May 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNTS
Momentus Inc. Stock $mnts